Supernus Pharmaceuticals
SUPN
#4182
Rank
HK$20.38 B
Marketcap
HK$355.60
Share price
1.29%
Change (1 day)
23.54%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of September 2025 : HK$11.05 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are HK$11.05 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$10.62 B6.44%
2023-12-31HK$9.97 B-24.98%
2022-12-31HK$13.30 B0.99%
2021-12-31HK$13.17 B12.96%
2020-12-31HK$11.66 B29.03%
2019-12-31HK$9.03 B18.01%
2018-12-31HK$7.65 B130.89%
2017-12-31HK$3.31 B38.15%
2016-12-31HK$2.40 B64.2%
2015-12-31HK$1.46 B37.8%
2014-12-31HK$1.06 B23.27%
2013-12-31HK$0.86 B18.14%
2012-12-31HK$0.72 B74.57%
2011-12-31HK$0.41 B14.07%
2010-12-31HK$0.36 B-40.95%
2009-12-31HK$0.61 B3.94%
2008-12-31HK$0.59 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$57.22 B 417.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$894.72 B 7,995.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$754.24 B 6,724.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$655.31 B 5,829.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$1.500 T 13,480.98%๐Ÿ‡บ๐Ÿ‡ธ USA